BMS to file for an injunction of generic sales prohibition against Dong-A ST
It was known that BMS has filed for an injunction to restrict sales against infringement of patent on Dong-A ST which has already launched a generic of ‘Baraclude,’ a mega-scale hepatitis B treatment, before its patent expiration.
This was a scheduled order. As surprisingly launching a Baraclude...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
